ask="5.29"
ask_size="2600"
average_daily_volume="343103"
bid="4.59"
bid_size="10000"
book_value="0.74"
change="+0.31"
change_from_200_day_moving_average="1.94"
change_from_50_day_moving_average="1.20"
change_from_52_week_high="-0.73"
change_From_52_week_low="3.48"
change_in_percent="+6.68%"
close="4.95"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.25"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.97"
high_52_weeks="5.68"
last_trade_date="3/17/2017"
last_trade_price="4.95"
last_trade_size="287985"
last_trade_time="4:00pm"
low="4.51"
low_52_weeks="1.47"
market_capitalization="169.03M"
moving_average_200_day="3.01"
moving_average_50_day="3.75"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="6.75"
open="4.76"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+64.32%"
percent_change_from_50_day_moving_average="+31.84%"
percent_change_from_52_week_high="-12.85%"
percent_change_from_52_week_low="+236.73%"
previous_close="4.64"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.24"
price_per_sales="35.60"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="0.90"
stock_exchange="NGM"
symbol="FATE"
volume="1010383"
weeks_range_52="1.47 - 5.68"
